Specifically, it has been found that hematopoietic mutations in common driver genes, DNMT3A, TET2, and JAK2V671F, can accelerate experimental atherosclerosis and/or heart failure by generating a pool of myeloid cells with an augmented proinflammatory profile [31]. The gene discussed is DNMT3A; the disease is atherosclerosis.